Flowable Hemostats Market Analysis and Forecast to 2031: By Material (Porcine Gelatin, Bovine Gelatin), Application (General Surgery, Cardiac Surgery, Vascular Surgery, Neuro & Spine Surgery, Orthopedic Surgery, Others), End Users (Hospitals, Clinics, and

Flowable Hemostats Market Analysis and Forecast to 2031: By Material (Porcine Gelatin, Bovine Gelatin), Application (General Surgery, Cardiac Surgery, Vascular Surgery, Neuro & Spine Surgery, Orthopedic Surgery, Others), End Users (Hospitals, Clinics, and Ambulatory Surgery Centers), and Region

The global flowable hemostats market was valued at USD 900 million in 2021 and it is anticipated to grow further till USD 1731.7 million in 2031 at a CAGR of 6.8% during the forecast period.

Flowable hemostats have flowable consistency and contain a porcine or bovine gelatin matrix. It may add topical thrombin. Flowable hemostats are helpful when an application is needed on a surface that is difficult to reach or in a wet field. The product can be used for all surgical procedures, except ophthalmic.

Global Flowable Hemostats Market Scope and Report StructureMarket Trends and Drivers

The management of prehospital haemorrhage is in high demand for hemostatic drugs. As a result, the market for flowable hemostats has the biggest income from applications related to general surgery. Due to its safety and efficacy profiles, this has increased the need for thrombin-gelatin hemostatic matrix in devices. For instance, FLOSEAL Hemostatic Matrix from Baxter International, a top producer of products for the treatment of life-threatening illnesses, is gaining popularity because it outperforms materials made of microporous polysaccharide powder.

Market Restraints and Challenges

The lack of awareness in developing countries is anticipated to hamper the growth of market. Bleeding disorders make up a sizable portion of disease burden in underdeveloped nations. The most prevalent bleeding illness in the world is Von Willebrand disease (VWD). Every year, 3 million people with VWD go undiagnosed worldwide, according to Health Grades, Inc. Developing nations like China and India have a high prevalence of Von Willebrand disease. Hence, the global market for flowable hemostats is anticipated to experience challenges during the projected period due to a lack of awareness regarding bleeding diseases in underdeveloped nations.

Global Flowable Hemostats Market Segmental Overview

The report analyses the global flowable hemostats market based on the material, application, end user, and region.

Global Flowable Hemostats Market by Material

Based on the material, it is segmented into porcine gelatin and bovine gelatin. The bovine gelatin segment is anticipated to dominate the market during the forecast period. Also, the segment is also anticipated to witness the fastest growth during the forecast period.

Global Flowable Hemostats Market by Application

Based on the application, it is segmented into general surgery, cardiac surgery, vascular surgery, neuro & spine surgery, orthopedic surgery, and others. The general surgery segment is anticipated to dominate the market during the forecast period. Similarly, the cardiac surgery segment is anticipated to witness the fastest growth during the forecast period.

Global Flowable Hemostats Market by End User

Based on the end user, it is segmented into hospitals, clinics, and ambulatory surgery centers. The hospital segment is anticipated to dominate the market during the forecast period. Similarly, the ambulatory surgery centers are anticipated to witness the fastest growth during the forecast period.

Geographical Analysis of the Global Flowable Hemostats Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North America region is anticipated to dominate the market during the forecast period. The use of flowable hemostats with thrombin-gelatin hemostatic matrix in procedures for the liver, the heart, and the sinuses has received a lot of attention. After penetrating trauma, there is an increasing need for flowable hemostats that can be used to deploy efficient hemostasis during partial splenectomy. Starch microspheres with tranexamic acid have potential for improving hemostatic stability. Additionally, it is anticipated that materials containing drugs will exhibit higher hemostatic function than commercial hemostats composed of microporous polysaccharide hemispheres.

Major Players in the Global Flowable Hemostats Market

The report analyses the various key players such as

COVID-19 Impact

In these trying times of the coronavirus (COVID-19) pandemic, healthcare companies in the flowable hemostats market are increasing the provision of life-sustaining medications and Medical Devices like flowable hemostats. To help satisfy the rising demand for their products, they are increasing the number of jobs available to people. Since COVID-19 is challenging communities and healthcare systems all over the world, expanding product supply chains is one of the main emphasis focuses for businesses in the flowable hemostats market. By making hemostats and other Medical Devices accessible around-the-clock, manufacturers are maximising their production efforts.

Recent Developments

• June 2019, Johnson & Johnson Ethicon won FDA clearance for airless spray devices to deliver Grifols fibrin sealant to stop surgical bleeding. The Vistaseal fibrin sealant was the first product introduced by Grifols as part of the global partnership with Johnson & Johnson and Ethicon.
• April 2019, Baxter International announced that it has received US Food and Drug Administration approval for faster preparation of its leading hemostatic, Floseal Hemostatic Matrix, at the 2019 Association of PeriOperative registered nurses Global Surgical Conference and Expo.
• January 2018, Baxter International agreed to acquire two hemostats and sealant products from Mallinckrodt plc, Recothrom, a thrombin topical and Preveleak surgical sealant, which are used in vascular reconstruction.

Frequently Asked Questions

Q1. How big is the Flowable Hemostats market?Ans. The global Flowable Hemostats market size was USD 900 Million in 2021 and is anticipated to reach USD 1731.7 Million in 2031, growing at a rate of 6.8% from 2022 to 2031.Q2. What is the Flowable Hemostats market growth rate?Ans. The growth rate of the Flowable Hemostats market is 6.8%.Q3. Which region holds a major market share for the Flowable Hemostats market?Ans. North America holds a major market share of the Flowable Hemostats market in 2021.Q4. Which segment accounted for the largest Flowable Hemostats market share?Ans. By End User, the hospitals segment accounted for the largest Flowable Hemostats market share.Q5. Who are the key players in the Flowable Hemostats market?Ans. The global Flowable Hemostats market report includes players such as Q6. What are the factors driving the Flowable Hemostats market growth?Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.Q7. What are the key growth strategies of Flowable Hemostats market players?Ans. The key growth strategies of Flowable Hemostats market players are product launch and product approval.Q8. Which region will provide more business opportunities for the Flowable Hemostats market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the Flowable Hemostats market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.